Healthcare & Life Sciences
Movetis
Belgium
acquiredacquired
acquired
Stage
About
Movetis was a biopharmaceutical company that developed and commercialized treatments for gastrointestinal disorders, with its lead product being the prokinetic agent prucalopride (marketed as Resolor) for chronic constipation.
Explore Movetis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.